Overview

"""This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well."" Jerry Avorn, Harvard Medical School. ""This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union."" Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.Regulating Pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies. Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors: Julia Abelson, Christa Altenstetter, Vittorio Bertele’, Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W. Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, Tom Walley."

Full Product Details

Author:   Elias Mossialos ,  Monique Mrazek ,  Tom Walley
Publisher:   Open University Press
Imprint:   Open University Press
Dimensions:   Width: 15.20cm , Height: 2.10cm , Length: 23.00cm
Weight:   0.550kg
ISBN:  

9780335214655

ISBN 10:   0335214657
Pages:   392
Publication Date:   16 June 2004
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Out of stock  
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Table of Contents

List of boxes, figures and tables List of contributors Series editors' introduction Foreword Preface Acknowledgments Regulating pharmaceuticals in europe: an overview The politics of pharmaceuticals in the European Union The European Community dimension: co-ordinating divergence The role of the EMEA in regulating pharmaceutical products Measuring, monitoring and evaluating policy outcomes in the pharmaceutical sector Regulating pharmaceutical prices in the European Union Reimbursement of pharmaceuticals in the European Union Good prescribing practice Patients and their medicines Financial incentives and prescribing Regulating pharmaceutical distribution and retail pharmacy in Europe Hospital pharmacies Influencing demand for drugs through cost sharing The off-patent pharmaceutical market The over-the-counter pharmaceutical market The implications of pharmacogenetics and pharmacogenomics for drug development and health care Should we pay for life-style drugs? Alternative medicines in Europe The pharmaceutical sector and regulation in the countries of Central and Eastern Europe Access to pharmaceuticals and regulation in the Commonwealth of Independent States A framework for containing costs fairly Index.

Reviews

This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well. - Jerry Avorn, Harvard Medical School.

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions